Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries.

Familial cancer - 1 Jan 2018

Brédart Anne, Kop Jean-Luc, Antoniou Antonis C, Cunningham Alex P, De Pauw Antoine, Tischkowitz Marc, Ehrencrona Hans, Dolbeault Sylvie, Robieux Léonore, Rhiem Kerstin, Easton Douglas F, Devilee Peter, Stoppa-Lyonnet Dominique, Schmutlzer Rita

Abstract excerpt

The 'BOADICEA' Web Application (BWA) used to assess breast cancer risk, is currently being further developed, to integrate additional genetic and non-genetic factors. We surveyed clinicians' perceived acceptability of the existing BWA v3. An online survey was conducted through the BOADICEA website, and the British, Dutch, French and Swedish genetics societies. Cross-sectional data from 443 participants who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Cross-Sectional Studies

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Multivariate Analysis

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 28623477
DOI: 10.1007/s10689-017-0014-x
PMCID: PMC5770489

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries.PMID 28623477Read ↗

The Pink Underside: The Commercialization of Medical Risk Assessment and Decision-Making Tools for Hereditary Breast Cancer Risk.Semantic proximity Read ↗

The Breast Cancer Genetic Testing Experience: Probing the Potential Utility of an Online Decision Aid in Risk Perception and Decision MakingSemantic proximity Read ↗

Clinical Implementation Study of Genetic Risk-Based Breast Cancer Screening.Semantic proximity Read ↗

The co-design, development, and preliminary evaluation of a comprehensive breast cancer risk report incorporating polygenic risk informationSemantic proximity Read ↗

Clinical software development for the Web: lessons learned from the BOADICEA project.Semantic proximity Read ↗

The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making.Semantic proximity Read ↗

Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study.Semantic proximity Read ↗

Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study.Semantic proximity Read ↗

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialSemantic proximity Read ↗

Are we ready for online tools in decision making for BRCA1/2 mutation carriers?Semantic proximity Read ↗

Clinically relevant lessons from Family HealthLink: a cancer and coronary heart disease familial risk assessment tool.Semantic proximity Read ↗

Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.